Advanced proteomic organ ageing is associated with the long-term risk of age-related diseases. In most cases, faster ageing ...
In a sample of 400 phase II trials that included 25,000 participants, a total of 4,045 patients (16.2%) received a treatment ...
Monroe Biomedical Research (MBR), a dedicated clinical trial site, is growing its footprint to enhance early-phase clinical ...
Metsera Inc. (MTSR), a New York-based biotech that went public on Jan. 31 with some fanfare, has a full portfolio of weight-loss drugs in development, using both the hormones already used in existing ...
Sterotherapeutics has initiated a Phase 2 clinical trial for ST-002, an innovative drug candidate aimed at treating Cushing’s ...
While decades of advocacy have pushed for the inclusion of women in clinical trials, a new study funded by Women’s Health ...
Fear of nuclear fallout has led to a novel therapeutic approach that could significantly extend the lives of individuals with ...
Find out how the virtual biotech company Libra Therapeutics leveraged data to accelerate drug development for ...
AMLX has had major setbacks in its lifecycle, including the voluntary withdrawal of an approved drug. Click here to find out ...
The ultimate goal is to develop the facility wherein Hawaii cancer patients will no longer need to travel out of state for ...
Glucagon-like peptite-1 (GLP-1) receptor agonists, such as Wegovy and Ozempic, have taken the food industry by storm. With ...
While main results from a platform study of four experimental drugs for amyotrophic lateral sclerosis are negative, it shows ...